Hollsteen
← Broadcom

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: $267M · 10-Q 0001649338-16-000019 filed Mar 10, 2016Research and development · Q2 FY2016: $787M · 10-Q 0001649338-16-000088 filed Jun 9, 2016Research and development · Q3 FY2016: $814M · 10-Q 0001649338-16-000104 filed Sep 8, 2016Research and development · Q4 FY2016: $806M · derived · 10-K 0001649338-17-000158 filed Dec 21, 2017Research and development · Q1 FY2017: $808M · 10-Q 0001649338-17-000027 filed Mar 9, 2017Research and development · Q2 FY2017: $829M · 10-Q 0001730168-18-000019 filed Jun 14, 2018Research and development · Q3 FY2017: $827M · 10-Q 0001730168-18-000039 filed Sep 13, 2018Research and development · Q4 FY2017: $828M · derived · 10-K 0001730168-18-000084 filed Dec 21, 2018Research and development · Q1 FY2018: $925M · 10-Q 0001730168-19-000036 filed Mar 15, 2019Research and development · Q2 FY2018: $936M · 10-Q 0001730168-18-000019 filed Jun 14, 2018Research and development · Q3 FY2018: $959M · 10-Q 0001730168-18-000039 filed Sep 13, 2018Research and development · Q4 FY2018: $948M · derived · 10-K 0001730168-19-000144 filed Dec 20, 2019Research and development · Q1 FY2019: $1.1B · 10-Q 0001730168-19-000036 filed Mar 15, 2019Research and development · Q2 FY2019: $1.2B · 10-Q 0001730168-19-000101 filed Jun 14, 2019Research and development · Q3 FY2019: $1.2B · 10-Q 0001730168-19-000118 filed Sep 13, 2019Research and development · Q4 FY2019: $1.2B · derived · 10-K 0001730168-20-000226 filed Dec 18, 2020Research and development · Q1 FY2020: $1.3B · 10-Q 0001730168-20-000045 filed Mar 13, 2020Research and development · Q2 FY2020: $1.3B · 10-Q 0001730168-20-000109 filed Jun 12, 2020Research and development · Q3 FY2020: $1.2B · 10-Q 0001730168-20-000164 filed Sep 11, 2020Research and development · Q4 FY2020: $1.2B · derived · 10-K 0001730168-21-000153 filed Dec 17, 2021Research and development · Q1 FY2021: $1.2B · 10-Q 0001730168-21-000045 filed Mar 12, 2021Research and development · Q2 FY2021: $1.2B · 10-Q 0001730168-21-000116 filed Jun 11, 2021Research and development · Q3 FY2021: $1.2B · 10-Q 0001730168-21-000123 filed Sep 9, 2021Research and development · Q4 FY2021: $1.2B · derived · 10-K 0001730168-22-000118 filed Dec 16, 2022Research and development · Q1 FY2022: $1.2B · 10-Q 0001730168-22-000029 filed Mar 10, 2022Research and development · Q2 FY2022: $1.3B · 10-Q 0001730168-22-000081 filed Jun 9, 2022Research and development · Q3 FY2022: $1.3B · 10-Q 0001730168-22-000094 filed Sep 8, 2022Research and development · Q4 FY2022: $1.2B · derived · 10-K 0001730168-23-000096 filed Dec 14, 2023Research and development · Q1 FY2023: $1.2B · 10-Q 0001730168-23-000008 filed Mar 8, 2023Research and development · Q2 FY2023: $1.3B · 10-Q 0001730168-23-000064 filed Jun 7, 2023Research and development · Q3 FY2023: $1.4B · 10-Q 0001730168-23-000077 filed Sep 6, 2023Research and development · Q4 FY2023: $1.4B · derived · 10-K 0001730168-24-000139 filed Dec 20, 2024Research and development · Q1 FY2024: $2.3B · 10-Q 0001730168-24-000023 filed Mar 14, 2024Research and development · Q2 FY2024: $2.4B · 10-Q 0001730168-24-000080 filed Jun 13, 2024Research and development · Q3 FY2024: $2.4B · 10-Q 0001730168-24-000099 filed Sep 11, 2024Research and development · Q4 FY2024: $2.2B · derived · 10-K 0001730168-25-000121 filed Dec 18, 2025Research and development · Q1 FY2025: $2.3B · 10-Q 0001730168-25-000021 filed Mar 12, 2025Research and development · Q2 FY2025: $2.7B · 10-Q 0001730168-25-000064 filed Jun 11, 2025Research and development · Q3 FY2025: $3.0B · 10-Q 0001730168-25-000098 filed Sep 10, 2025Research and development · Q4 FY2025: $3.0B · derived · 10-K 0001730168-25-000121 filed Dec 18, 2025Research and development · Q1 FY2026: $3.0B · 10-Q 0001730168-26-000016 filed Mar 11, 2026Research and development · Q2 FY2026: $3.0B · 10-Q 0001730168-26-000054 filed Jun 9, 2026Research and development · Q3 FY2026: $2.9B · 10-Q 0001730168-26-000080 filed Sep 10, 20262,981a2,895267Q1 FY2016Q3 FY2026
$MResearch and development · Q4 FY2024: $2.2B · derived · 10-K 0001730168-25-000121 filed Dec 18, 2025Research and development · Q1 FY2025: $2.3B · 10-Q 0001730168-25-000021 filed Mar 12, 2025Research and development · Q2 FY2025: $2.7B · 10-Q 0001730168-25-000064 filed Jun 11, 2025Research and development · Q3 FY2025: $3.0B · 10-Q 0001730168-25-000098 filed Sep 10, 2025Research and development · Q4 FY2025: $3.0B · derived · 10-K 0001730168-25-000121 filed Dec 18, 2025Research and development · Q1 FY2026: $3.0B · 10-Q 0001730168-26-000016 filed Mar 11, 2026Research and development · Q2 FY2026: $3.0B · 10-Q 0001730168-26-000054 filed Jun 9, 2026Research and development · Q3 FY2026: $2.9B · 10-Q 0001730168-26-000080 filed Sep 10, 20262,981a2,8952,234aQ4 FY2024Q3 FY2026Q4 FY2025
Q4 FY2025
2,981a$M
derived
All values (43)
PeriodValue ($M)Status
Q3 FY20262,895reported
Q2 FY20262,995reported
Q1 FY20262,965reported
Q4 FY20252,981derived
Q3 FY20253,050reported
Q2 FY20252,693reported
Q1 FY20252,253reported
Q4 FY20242,234derived
Q3 FY20242,353reported
Q2 FY20242,415reported
Q1 FY20242,308reported
Q4 FY20231,388derived
Q3 FY20231,358reported
Q2 FY20231,312reported
Q1 FY20231,195reported
Q4 FY20221,197derived
Q3 FY20221,255reported
Q2 FY20221,261reported
Q1 FY20221,206reported
Q4 FY20211,200derived
Q3 FY20211,205reported
Q2 FY20211,238reported
Q1 FY20211,211reported
Q4 FY20201,182derived
Q3 FY20201,228reported
Q2 FY20201,269reported
Q1 FY20201,289reported
Q4 FY20191,177derived
Q3 FY20191,235reported
Q2 FY20191,151reported
Q1 FY20191,133reported
Q4 FY2018948derived
Q3 FY2018959reported
Q2 FY2018936reported
Q1 FY2018925reported
Q4 FY2017828derived
Q3 FY2017827reported
Q2 FY2017829reported
Q1 FY2017808reported
Q4 FY2016806derived
Q3 FY2016814reported
Q2 FY2016787reported
Q1 FY2016267reported

CSV with all sources · Technical ID: rnd

More metrics for Broadcom

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Sources & calculation
Value
$3.0B (derived)
Period
Q4 FY2025, ended Nov 2, 2025 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 10,977M − 7,996M = $3.0B (FY value from 10-K 0001730168-25-000121; 9-month value from the Q3-10-Q)
Source
10-K, filed Dec 18, 2025 · 0001730168-25-000121
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$3.0BDec 18, 202510-K 0001730168-25-000121derived · confidence 1. · current